EILEEN INGENITO: Open Payments
NPI 1386731784 · COMMACK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 12 payments from 10 companies in 2025. Trend: 2023 $1,171 · 2024 $858 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $283 |
| Amgen Inc. | 1 | $150 |
| Alexion Pharmaceuticals, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $118 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Corium, LLC | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: INGREZZA, KRYSTEXXA, KOSELUGO, AIRSUPRA, COBENFY, REXULTI, Azstarys, PREVNAR 20.
Industry payments across NY — which companies pay providers there.
